Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Clinical trial NCT03098160 · UNKNOWN

Trial details

NCT number: NCT03098160
Sponsor: Threshold Pharmaceuticals
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer Melanoma Squamous Cell Carcinoma of the Head and Neck Prostate Cancer

Start date: 2017-05-10
Primary completion: 2019-01-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.